The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, ...

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and ...

With approximately one third of all current FDA-approved drugs targeting GPCRs ... technologies to translational research with the goal of accelerating the development of therapeutics, biomarkers ...

Caitlin Mills discusses the drug screening assay her lab developed to investigate small molecule kinase inhibitors.

New research has detailed each type, helping to uncover targets for drug development and identify potential effective second-line therapies. Ubiquigent Limited (“Ubiquigent”), a drug discovery ...

Drug discovery has traditionally been slow ... are starting to harness quantum computing to improve their research and development (R&D) pipelines, as reported by McKinsey & Co. By leveraging ...

The influence of AI in drug development has gained such importance that it has been termed a revolution. Let’s explore how ...

It leverages AI and machine learning to automate workflows, enabling scientists to manage complex biological data with greater accuracy.

Pfizer (PFE, Financials) announced plans to invest $1 billion in China over the next five years to enhance research and ...

Machine learning in drug discovery, along with artificial intelligence, is transforming the pharmaceutical industry by accelerating the development ... from AI-driven research methods, according ...

The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug ...

A grant from the National Institutes of Health will help Wayne State University researchers explore new avenues for using ...